19 related articles for article (PubMed ID: 2064343)
1. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.
Plosker GL; Faulds D
Drugs; 1993 May; 45(5):788-856. PubMed ID: 7686469
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pump.
Peretz T; Freund HR; Isacson R; Ben-Yosef A; Goldin E; Haskel L; Chisin R; Biran S; Durst AL
Isr J Med Sci; 1988; 24(9-10):562-7. PubMed ID: 2849596
[TBL] [Abstract][Full Text] [Related]
5. Intermittent percutaneous infusion into the hepatic artery of cytotoxic drugs for hepatic tumours.
Falk RE; Greig P; Makowka L; Ambus U; Ropchan G; Larratt L; Langer B; Taylor BR; Hobbs BB; Colapointo RF; Bugala R; Gollish C; Kalman P
Can J Surg; 1982 Jan; 25(1):47-50. PubMed ID: 7055763
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study.
Nobile MT; Vidili MG; Sertoli MR; Venturini M; Simoni G; Civalleri D; Bertoglio S; Percivale P; Torelli P; Spagliardi E
Anticancer Res; 1991; 11(2):861-4. PubMed ID: 2064343
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
Gerard A; Pector JC; Bleiberg H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
[TBL] [Abstract][Full Text] [Related]
8. Contributions to the treatment of primary liver cancer. 4'-epidoxorubicin and cisplatin studied in hepatocarcinoma cell cultures and in partially hepatectomized rats.
Hall KS
Scand J Clin Lab Invest; 1993 Apr; 53(2):101-9. PubMed ID: 8469909
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
